Want to see XRAY full AI Analyst Report?
Net Sales by Segment
Maps sales across the company’s reported segments to show which product lines generate the most revenue and how they trend over time. This helps assess whether growth is broad-based or concentrated and how segment mix may influence overall margins and cash flow.DENTSPLY SIRONA's Connected Technology and Orthodontic & Implant segments are experiencing a downward trend, exacerbated by U.S. sales declines and tariff impacts. Despite these challenges, the Essential Dental and Wellspect Healthcare segments show resilience, with Wellspect maintaining steady growth. The earnings call highlighted a 5% decline in global sales and significant impairment charges, but also noted improved EBITDA margins due to cost reductions. The DS Core platform's growth and Germany's sales performance offer some positive momentum amid broader market pressures.
Date | Connected Technology | Essential Dental | Orthodontic & Implant | Wellspect Healthcare | Technologies & Equipment | Consumables |
|---|---|---|---|---|---|---|
Jun 30, 2025 | $243.00M | $387.00M | $226.00M | $80.00M | $0.00 | $0.00 |
Mar 31, 2025 | $235.00M | $353.00M | $217.00M | $74.00M | $0.00 | $0.00 |
Dec 31, 2024 | $293.00M | $346.00M | $185.00M | $81.00M | $0.00 | $0.00 |
Sep 30, 2024 | $269.00M | $369.00M | $241.00M | $72.00M | $0.00 | $0.00 |
Jun 30, 2024 | $253.00M | $375.00M | $276.00M | $80.00M | $0.00 | $0.00 |
Mar 31, 2024 | $247.00M | $364.00M | $271.00M | $71.00M | $0.00 | $0.00 |
Dec 31, 2023 | $319.00M | $358.00M | $259.00M | $76.00M | $0.00 | $0.00 |
Sep 30, 2023 | $276.00M | $347.00M | $252.00M | $72.00M | $0.00 | $0.00 |
Jun 30, 2023 | $309.00M | $377.00M | $270.00M | $72.00M | $0.00 | $0.00 |
Mar 31, 2023 | $265.00M | $386.00M | $259.00M | $68.00M | $0.00 | $0.00 |